Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
xc6LrBvpk1P9y2g2
Écouter
Français